ホーム › 肝臓がん（肝細胞がん） › オハイオ › Cleveland
Cleveland、OHにおける肝臓がん（肝細胞がん）の臨床試験
Clevelandとその周辺地域（約30マイル以内）の拠点で、肝臓がん（肝細胞がん）に関する18件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
The Vanguard Study: Testing a New Way to Screen for Cancer
被験者募集中健康なボランティア歓迎
- Louis Stokes Cleveland VA Medical Center, Cleveland
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
被験者募集中第1相
- Exelixis Clinical Site #10, Cleveland
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
被験者募集中第1/2相
- University Hospitals Cleveland Medical Center, Cleveland
National Liver Cancer Screening Trial
被験者募集中第4相
- The Cleveland Clinic, Cleveland
A Study Evaluating a New Radiation Treatment Workflow (NGDS)
被験者募集中
- University Hospital Cleveland Medical Center, Cleveland
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
被験者募集中観察研究
- Cleveland Clinic Foundation, Cleveland
FOG-001 in Locally Advanced or Metastatic Solid Tumors
被験者募集中第1/2相
- University Hospitals Cleveland Medical Center, Seidman Cancer Center, Cleveland
- Cleveland Clinic, Cleveland
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
被験者募集中第3相
- Case Western Reserve University, Cleveland
- UHHS-Chagrin Highlands Medical Center, Beachwood · 10マイル先
- UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor · 22マイル先
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
被験者募集中第1相
- University Hospitals Cleveland Medical Center, Cleveland
DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.
被験者募集中観察研究
- Cleveland Clinic, Cleveland
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
被験者募集中第1相
- Clinical Trial Site, Cleveland
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
被験者募集中
- Louis Stokes VA Medical Center, Cleveland, OH, Cleveland
68Ga-PSMA-11 PET-directed Radioligand Therapy in Metastatic Hepatocellular Carcinoma (HCC)
被験者募集中第2相
- Case Comprehensive Cancer Center, University Hospitals Cleveland Medical Center, Seidman Cancer Center, Cleveland
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
被験者募集中第1/2相
- Cleveland Clinic Lerner College of Medicine, Cleveland
HOPE Against Cancer Recurrence in HCC
被験者募集中第4相
- Cleveland Clinic, Cleveland
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, Mayfield Heights · 12マイル先
The Dragon PLC Trial (DRAGON-PLC)
被験者募集中
- Cleveland Clinic, Cleveland
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
被験者募集中第1/2相
- Cleveland Clinic, Cleveland
他の都市における肝臓がん（肝細胞がん）の試験
- Houston, TX31件の研究
- New York City, NY24件の研究
- Dallas, TX19件の研究
- Los Angeles, CA19件の研究
- Boston, MA18件の研究
- Chicago, IL16件の研究
- Philadelphia, PA16件の研究
- Pittsburgh, PA15件の研究
- San Francisco, CA14件の研究
- Orange, CA14件の研究
- Jacksonville, FL14件の研究
- San Antonio, TX13件の研究
Clevelandにおける他の研究
- 非小細胞肺癌43件の研究
- がん（全種類）36件の研究
- 乳がん35件の研究
- 前立腺がん34件の研究
- 心不全33件の研究
- 卵巣がん30件の研究
- 転移性癌30件の研究
- 肺がん26件の研究
- 大腸癌24件の研究
- 心血管疾患22件の研究
- 子宮内膜がん20件の研究
- 急性骨髄性白血病20件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。